S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Sports analytics may be outnumbered when it comes to artificial intelligence
Critical asset just had biggest fall on record (Ad)
Nobel laureate Muhammad Yunus is granted bail in a Bangladesh graft case
South Korean doctors hold massive anti-government rally over medical school recruitment plan
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
What to watch for as China's major political meeting of the year gets underway
Former Bank of Beijing chairman under investigation, part of China's crackdown on corruption
NYSE:MDT

Medtronic (MDT) Stock Price, News & Analysis

$83.60
+0.24 (+0.29%)
(As of 03/1/2024 ET)
Today's Range
$82.65
$83.85
50-Day Range
$81.92
$88.09
52-Week Range
$68.84
$92.02
Volume
4.27 million shs
Average Volume
6.24 million shs
Market Capitalization
$111.01 billion
P/E Ratio
26.62
Dividend Yield
3.30%
Price Target
$94.91

Medtronic MarketRank™ Stock Analysis

Analyst Rating
Hold
2.45 Rating Score
Upside/​Downside
13.5% Upside
$94.91 Price Target
Short Interest
Healthy
0.74% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.12
Upright™ Environmental Score
News Sentiment
0.46mentions of Medtronic in the last 14 days
Based on 17 Articles This Week
Insider Trading
Selling Shares
$3.02 M Sold Last Quarter
Proj. Earnings Growth
4.81%
From $5.20 to $5.45 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.82 out of 5 stars

Medical Sector

37th out of 950 stocks

Electromedical Equipment Industry

2nd out of 21 stocks


MDT stock logo

About Medtronic Stock (NYSE:MDT)

Medtronic PLC is a world-leading medical technology company that develops and manufactures device-based medical therapies to improve patient outcomes. Founded in 1949 in Minneapolis, Minnesota, Medtronic has grown to become one of the largest medical device companies in the world. The company's operational and executive headquarters are in Dublin, Ireland, with over 90,000 employees in more than 150 countries.

Medtronic's portfolio of medical technologies includes products for diagnosing, treating and managing cardiac rhythm disorders and cardiovascular disease, spinal and biologics, diabetes management and neuromodulation. The company's cardiac and vascular group is the oldest and largest business unit, which develops pacemakers, defibrillators and heart valves. Medtronic's spinal and biologics business is the second-largest business unit and produces a range of implants, instruments and services to treat spinal disorders. The diabetes group develops insulin pumps, continuous glucose monitoring systems and consumables. At the same time, the neuromodulation business focuses on therapies to treat chronic pain, movement disorders and other neurological conditions.

In 2015, Medtronic acquired Covidien PLC, an Irish-based medical technology company, and moved its legal headquarters to Ireland. This transaction was the most significant U.S. corporate tax inversion in history and allowed the company to take advantage of lower corporate taxes in Ireland. The company also achieved a 100% gender and ethnically diverse pay equity in the U.S. and 99% gender pay equity globally, as reported in its Global Inclusion, Diversity and Equity 2022 annual report. Medtronic joined the Bloomberg Gender-Equality Index (GEI) in 2023, becoming one of the 483 companies listed in the index. 

Medtronic's stock is traded on the New York Stock Exchange (NYSE) under the ticker symbol MDT and is a member of the S&P 500 and the Dow Jones Industrial Average (DJIA). The company has had several recent recalls, including the HeartWare Ventricular Assist Device in February 2021 and the controller ports in June 2021. 

Medtronic has continued to focus on developing its medical technology portfolio and announced several acquisitions and partnerships in 2021. In January, the company announced its intention to acquire Affera, Inc., Stimgenics LLC and Medicrea. In May, Medtronic announced a strategic partnership with CathWorks, and in March 2022, a contract with Vizient. The company is also working with GE Healthcare to support the needs and care demands at Ambulatory Surgery Centers in April 2022. In October 2022, Medtronic announced its intention to pursue a separation of the company's combined patient monitoring and respiratory interventions businesses. 

Medtronic PLC is a world-leading medical technology company that has grown to become one of the largest medical device companies in the world. With its portfolio of medical technologies and recent acquisitions and partnerships, the company is well-positioned to capitalize on the growth of the medical device industry. The company's commitment to gender and ethnic pay equity and inclusion and its strategic partnerships and acquisitions make Medtronic PLC an attractive option for investors looking for a long-term growth opportunity.

MDT Stock Price History

MDT Stock News Headlines

MDT Mar 2024 89.000 put
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
MDT Mar 2024 70.000 put
Where Will Medtronic Stock Be in 3 Years?
Medtronic (NYSE:MDT) Given New $92.00 Price Target at Oppenheimer
Medtronic (NYSE:MDT) Price Target Raised to $98.00 at Mizuho
Medtronic price target raised by $3 at Truist, here's why
Medtronic’s Strong Financials and Strategic Focus Justify Buy Rating
Expert Ratings For Medtronic
See More Headlines
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/12 Dividend
12/19/2023
Dividend Payable
1/12/2024
Last Earnings
2/20/2024
Today
3/03/2024
Fiscal Year End
4/30/2024
Next Earnings (Estimated)
5/23/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
Health Care Equipment
CUSIP
58505510
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Target
$94.91
High Stock Price Target
$106.00
Low Stock Price Target
$82.00
Potential Upside/Downside
+13.5%
Consensus Rating
Hold
Rating Score (0-4)
2.45
Research Coverage
11 Analysts

Profitability

Net Income
$3.76 billion
Pretax Margin
17.11%

Debt

Sales & Book Value

Annual Sales
$31.23 billion
Cash Flow
$7.35 per share
Book Value
$39.16 per share

Miscellaneous

Outstanding Shares
1,327,820,000
Free Float
1,323,840,000
Market Cap
$111.01 billion
Optionable
Optionable
Beta
0.76

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Should I Buy Medtronic Stock? MDT Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Medtronic was last updated on Friday, March 1, 2024 at 9:10 PM.

Pros

Here are some ways that investors could benefit from investing in Medtronic plc:

  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
  • The company offers a wide range of products including cardiac rhythm and heart failure management, diabetes, and minimally invasive therapies.
  • Medtronic plc has a strong track record of innovation and product development in the medical device industry.
  • Recent developments include the launch of monitoring systems, smart insulin pen systems, and consumables and supplies.
  • The current stock price of Medtronic plc is favorable for potential investors.

Cons

Investors should be bearish about investing in Medtronic plc for these reasons:

  • While Medtronic plc has a strong product portfolio, competition in the medical device industry is intense.
  • Regulatory challenges and changes in healthcare policies could impact the company's operations and profitability.
  • Market volatility and economic uncertainties may affect the stock performance of Medtronic plc.
  • Investing in healthcare companies like Medtronic plc carries inherent risks related to clinical trials and product approvals.
  • Fluctuations in currency exchange rates could impact Medtronic plc's international operations and financial results.














MDT Stock Analysis - Frequently Asked Questions

Should I buy or sell Medtronic stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 1 sell rating, 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" MDT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDT, but not buy additional shares or sell existing shares.
View MDT analyst ratings
or view top-rated stocks.

What is Medtronic's stock price target for 2024?

11 brokers have issued 12 month price objectives for Medtronic's stock. Their MDT share price targets range from $82.00 to $106.00. On average, they expect the company's share price to reach $94.91 in the next twelve months. This suggests a possible upside of 13.5% from the stock's current price.
View analysts price targets for MDT
or view top-rated stocks among Wall Street analysts.

How have MDT shares performed in 2024?

Medtronic's stock was trading at $82.38 on January 1st, 2024. Since then, MDT shares have increased by 1.5% and is now trading at $83.60.
View the best growth stocks for 2024 here
.

When is Medtronic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024.
View our MDT earnings forecast
.

How were Medtronic's earnings last quarter?

Medtronic plc (NYSE:MDT) released its earnings results on Tuesday, February, 20th. The medical technology company reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.26 by $0.04. The medical technology company had revenue of $8.09 billion for the quarter, compared to analyst estimates of $7.95 billion. Medtronic had a trailing twelve-month return on equity of 13.71% and a net margin of 13.00%. The firm's quarterly revenue was up 4.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.30 EPS.
Read the conference call transcript
.

How often does Medtronic pay dividends? What is the dividend yield for Medtronic?

Medtronic announced a quarterly dividend on Thursday, December 7th. Investors of record on Wednesday, December 20th will be given a dividend of $0.69 per share on Friday, January 12th. This represents a $2.76 annualized dividend and a dividend yield of 3.30%. The ex-dividend date of this dividend is Tuesday, December 19th.
Read our dividend analysis for MDT
.

Is Medtronic a good dividend stock?

Medtronic (NYSE:MDT) pays an annual dividend of $2.76 per share and currently has a dividend yield of 3.30%. The company has been increasing its dividend for 47 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 87.90%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MDT will have a dividend payout ratio of 50.64% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MDT.

What guidance has Medtronic issued on next quarter's earnings?

Medtronic updated its FY 2024 earnings guidance on Tuesday, February, 20th. The company provided earnings per share guidance of 5.190-5.210 for the period, compared to the consensus earnings per share estimate of 5.160. The company issued revenue guidance of $32.1 billion-$32.3 billion, compared to the consensus revenue estimate of $32.1 billion.

What is Omar S. Ishrak's approval rating as Medtronic's CEO?

1,925 employees have rated Medtronic Chief Executive Officer Omar S. Ishrak on Glassdoor.com. Omar S. Ishrak has an approval rating of 92% among the company's employees. This puts Omar S. Ishrak in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medtronic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medtronic investors own include Johnson & Johnson (JNJ), AT&T (T), NVIDIA (NVDA), AbbVie (ABBV), Walt Disney (DIS), Cisco Systems (CSCO), Intel (INTC), CVS Health (CVS), Home Depot (HD) and Walmart (WMT).

Who are Medtronic's major shareholders?

Medtronic's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.52%), Massachusetts Financial Services Co. MA (2.17%), Capital Research Global Investors (2.17%), Franklin Resources Inc. (1.46%), Price T Rowe Associates Inc. MD (1.16%) and Norges Bank (1.12%). Insiders that own company stock include Bradley E Lerman, Brett A Wall, Brett A Wall, Carol A Surface, Geoffrey Martha, Gregory L Smith, Hoedt Rob Ten, John R Liddicoat, Karen L Parkhill, Karen L Parkhill, Michael Marinaro, Richard H Anderson, Robert John White and Sean Salmon.
View institutional ownership trends
.

How do I buy shares of Medtronic?

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:MDT) was last updated on 3/3/2024 by MarketBeat.com Staff